Surveillance of Employees of Swiss Federal Asylum Centres for Latent Tuberculosis Infection.

BACKGROUND: Asylum seekers in Switzerland have to register in federal asylum centres (FACs) before formal permission to enter the country. Some of them may have active tuberculosis (TB), exposing fellow refugees and employees. OBJECTIVES: The aim of this study was to assess the risk of TB infection among employees of Swiss FACs. METHODS: Between 2010 and 2018, a free interferon-gamma release assay (IGRA) was offered to all employees of 8 FACs, at employment and at yearly intervals. We defined latent TB infection as IGRA conversion from negative to positive. IGRA-positive employees were referred to a medical centre for further clinical follow-up. RESULTS: 1,427 tests were performed among 737 employees (54.6% male). 403 (55%) persons were tested only once; 330 (44.5%) were tested several times; for 4 (0.5%) persons, the number of IGRA tests is unknown. Twenty employees (2.7%) had a positive IGRA at baseline, 2 (0.6%) converted from negative to positive during follow-up, resulting in an incidence of 22/10,000 person-years. We observed no case of active TB among employees. CONCLUSIONS: The prevalence of latent TB among employees to Swiss FACs and the risk of acquiring TB infection through work-related exposure are low. Yearly IGRA controls in the absence of documented TB exposure seem unnecessary

High Precision Test of the Pauli Exclusion Principle for Electrons

The VIP-2 experiment aims to perform high precision tests of the Pauli Exclusion Principle for electrons. The method consists in circulating a continuous current in a copper strip, searching for the X radiation emission due to a prohibited transition (from the 2p level to the 1s level of copper when this is already occupied by two electrons). VIP already set the best limit on the PEP violation probability for electrons $\frac{1}{2} \beta^2 < 4.7 \times 10^{-29}$, the goal of the upgraded VIP-2 (VIolation of the Pauli Exclusion Principle-2) experiment is to improve this result of two orders of magnitude at least. The experimental apparatus and the results of the analysis of a first set of collected data will be presented

Search for a remnant violation of the Pauli exclusion principle in a Roman lead target

In this paper we report on the results of two analyses of the data taken with a dedicated VIP-Lead experiment at the Gran Sasso National Laboratory of the INFN. We use measurements taken in an environment that is especially well screened from cosmic rays, with a metal target made of “Roman lead” which is characterised by a low level of intrinsic radioactivity. The analyses lead to an improvement, on the upper bounds of the Pauli Exclusion Principle violation for electrons, which is more than one (four) orders of magnitude, when the electron-atom interactions are described in terms of scatterings (or close encounters) respectively

Test of the Pauli Exclusion Principle in the VIP-2 Underground Experiment

The validity of the Pauli exclusion principle\u2014a building block of Quantum Mechanics\u2014is tested for electrons. The VIP (violation of Pauli exclusion principle) and its follow-up VIP-2 experiments at the Laboratori Nazionali del Gran Sasso search for X-rays from copper atomic transitions that are prohibited by the Pauli exclusion principle. The candidate events\u2014if they exist\u2014originate from the transition of a 2p orbit electron to the ground state which is already occupied by two electrons. The present limit on the probability for Pauli exclusion principle violation for electrons set by the VIP experiment is 4.7 710^ 1229. We report a first result from the VIP-2 experiment improving on the VIP limit, which solidifies the final goal of achieving a two orders of magnitude gain in the long run

HIGH SENSITIVITY QUANTUM MECHANICS TESTS IN THE COSMIC SILENCE

The VIP experiment aims to perform high-precision tests of the Pauli Exclusion Principle for electrons in the extremely low cosmic background environment of the Underground Gran Sasso Laboratories of INFN (Italy). The experimental technique consists in introducing a DC current in a copper conductor, searching for K α PEP-forbidden atomic transitions when the K shell is already occupied by two electrons. The results of a preliminary data analysis, corresponding to the first run of the VIP-2 data taking (2016–2017), are presented. The experimental setup in the final configuration is described together with preliminary spectra from the 2019 data-taking campaign

NEW CONCEPTS IN TESTS OF THE PAULI EXCLUSION PRINCIPLE IN BULK MATTER

The standard scheme of several tests of the Pauli Exclusion Principle in bulk matter — both in the experiment and in the subsequent data analysis — has long been based on the seminal paper by E. Ramberg, G.A. Snow [Phys. Lett. B 238, 438 (1990)]. The ideas exposed in that paper are so simple and immediate that they have long gone unchallenged. However, while some of the underlying approximations are still valid, other parts of the article must be reconsidered. Here, we discuss some new concepts that are related to the motion of the electrons in the test metal (the “target” of the experiment) and which have been recently studied in the framework of the VIP-2 Collaboration

On the Importance of Electron Diffusion in a Bulk-Matter Test of the Pauli Exclusion Principle

The VIolation of Pauli (VIP) experiment (and its upgraded version, VIP-2) uses the Ramberg and Snow (RS) method (Phys. Lett. B 1990, 238, 438) to search for violations of the Pauli exclusion principle in the Gran Sasso underground laboratory. The RS method consists of feeding a copper conductor with a high direct current, so that the large number of newly-injected conduction electrons can interact with the copper atoms and possibly cascade electromagnetically to an already occupied atomic ground state if their wavefunction has the wrong symmetry with respect to the atomic electrons, emitting characteristic X-rays as they do so. In their original data analysis, RS considered a very simple path for each electron, which is sure to return a bound, albeit a very weak one, because it ignores the meandering random walks of the electrons as they move from the entrance to the exit of the copper sample. These complex walks bring the electrons close to many more atoms than in the RS calculation. Here, we consider the full description of these walks and show that this leads to a nontrivial and nonlinear X-ray emission rate. Finally, we obtain an improved bound, which sets much tighter constraints on the violation of the Pauli exclusion principle for electrons

Predictors for prolonged hospital stay solely to complete intravenous antifungal treatment in patients with candidemia: Results from the ECMM candida III multinational European observational cohort study

Background To date, azoles represent the only viable option for oral treatment of invasive Candida infections, while rates of azole resistance among non-albicans Candida spp. continue to increase. The objective of this sub-analysis of the European multicenter observational cohort study Candida III was to describe demographical and clinical characteristics of the cohort requiring prolonged hospitalization solely to complete intravenous (iv) antifungal treatment (AF Tx). Methods Each participating hospital (number of eligible hospitals per country determined by population size) included the first ~ 10 blood culture proven adult candidemia cases occurring consecutively after July 1st, 2018, and treating physicians answered the question on whether hospital stay was prolonged only for completion of intravenous antifungal therapy. Descriptive analyses as well as binary logistic regression was used to assess for predictors of prolonged hospitalization solely to complete iv AF Tx. Findings Hospital stay was prolonged solely for the completion of iv AF Tx in 16% (100/621) of candidemia cases by a median of 16 days (IQR 8 – 28). In the multivariable model, initial echinocandin treatment was a positive predictor for prolonged hospitalization to complete iv AF Tx (aOR 2.87, 95% CI 1.55 – 5.32, p < 0.001), while (i) neutropenia, (ii) intensive care unit admission, (iii) catheter related candidemia, (iv) total parenteral nutrition, and (v) C. parapsilosis as causative pathogen were found to be negative predictors (aOR 0.22 – 0.45; p < 0.03). Interpretation Hospital stays were prolonged due to need of iv AF Tx in 16% of patients with candidemia. Those patients were more likely to receive echinocandins as initial treatment and were less severely ill and less likely infected with C. parapsilosis

Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

© 2022 Elsevier Ltd. All rights reserved.[Background] The European Confederation of Medical Mycology (ECMM) collected data on epidemiology, risk factors, treatment, and outcomes of patients with culture-proven candidaemia across Europe to assess how adherence to guideline recommendations is associated with outcomes.[Methods] In this observational cohort study, 64 participating hospitals located in 20 European countries, with the number of eligible hospitals per country determined by population size, included the first ten consecutive adults with culture-proven candidaemia after July 1, 2018, and entered data into the ECMM Candida Registry (FungiScope CandiReg). We assessed ECMM Quality of Clinical Candidaemia Management (EQUAL Candida) scores reflecting adherence to recommendations of the European Society of Clinical Microbiology and Infectious Diseases and the Infectious Diseases Society of America guidelines.[Findings] 632 patients with candidaemia were included from 64 institutions. Overall 90-day mortality was 43% (265/617), and increasing age, intensive care unit admission, point increases in the Charlson comorbidity index score, and Candida tropicalis as causative pathogen were independent baseline predictors of mortality in Cox regression analysis. EQUAL Candida score remained an independent predictor of mortality in the multivariable Cox regression analyses after adjusting for the baseline predictors, even after restricting the analysis to patients who survived for more than 7 days after diagnosis (adjusted hazard ratio 1·08 [95% CI 1·04–1·11; p<0·0001] in patients with a central venous catheter and 1·09 [1·05–1·13; p<0·0001] in those without one, per one score point decrease). Median duration of hospital stay was 15 days (IQR 4–30) after diagnosis of candidaemia and was extended specifically for completion of parenteral therapy in 100 (16%) of 621 patients. Initial echinocandin treatment was associated with lower overall mortality and longer duration of hospital stay among survivors than treatment with other antifungals.[Interpretation] Although overall mortality in patients with candidaemia was high, our study indicates that adherence to clinical guideline recommendations, reflected by higher EQUAL Candida scores, might increase survival. New antifungals, with similar activity as current echinocandins but with longer half-lives or oral bioavailability, are needed to reduce duration of hospital stay.Scynexis.Peer reviewe